Depreciation of Tempest Therapeutics, Inc. from 31 Dec 2017 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Tempest Therapeutics, Inc. quarterly and annual Depreciation in USD history and change rate from 31 Dec 2017 to 30 Sep 2025.
  • Tempest Therapeutics, Inc. Depreciation for the quarter ending 30 Sep 2025 was $66,000, a 33% decline year-over-year.
  • Tempest Therapeutics, Inc. Depreciation for the twelve months ending 30 Sep 2025 was $249,000, a 42% decline year-over-year.
  • Tempest Therapeutics, Inc. annual Depreciation for 2024 was $389,000, a 2.1% increase from 2023.
  • Tempest Therapeutics, Inc. annual Depreciation for 2023 was $381,000, a 40% decline from 2022.
  • Tempest Therapeutics, Inc. annual Depreciation for 2022 was $638,000, a 71% increase from 2021.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Tempest Therapeutics, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $249,000 $66,000 -$32,000 -33% 01 Jul 2025 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $281,000 $67,000 -$88,000 -57% 01 Apr 2025 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 $369,000 $68,000 -$20,000 -23% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $389,000 $48,000 -$37,000 -44% 01 Oct 2024 31 Dec 2024 10-K 27 Mar 2025 2024 FY
Q3 2024 $426,000 $98,000 +$10,000 +11% 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025 2025 Q3
Q2 2024 $416,000 $155,000 +$72,000 +87% 01 Apr 2024 30 Jun 2024 10-Q 11 Aug 2025 2025 Q2
Q1 2024 $344,000 $88,000 -$37,000 -30% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q1
Q4 2023 $381,000 $85,000 -$132,000 -61% 01 Oct 2023 31 Dec 2023 10-K 27 Mar 2025 2024 FY
Q3 2023 $513,000 $88,000 -$113,000 -56% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 $626,000 $83,000 -$29,000 -26% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 $655,000 $125,000 +$17,000 +16% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 $638,000 $217,000 +$114,000 +111% 01 Oct 2022 31 Dec 2022 10-K 19 Mar 2024 2023 FY
Q3 2022 $524,000 $201,000 +$94,000 +88% 01 Jul 2022 30 Sep 2022 10-Q 08 Nov 2023 2023 Q3
Q2 2022 $430,000 $112,000 +$26,000 +30% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q1 2022 $404,000 $108,000 +$30,000 +38% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023 2023 Q1
Q4 2021 $374,000 $103,000 -$38,000 -27% 01 Oct 2021 31 Dec 2021 10-K 22 Mar 2023 2022 FY
Q3 2021 $412,000 $107,000 +$26,000 +32% 01 Jul 2021 30 Sep 2021 10-Q 08 Nov 2022 2022 Q3
Q2 2021 $386,000 $86,000 +$6,000 +7.5% 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022 2022 Q2
Q1 2021 $380,000 $78,000 +$41,000 +111% 01 Jan 2021 31 Mar 2021 10-Q 13 May 2022 2022 Q1
Q4 2020 $339,000 $141,000 01 Oct 2020 31 Dec 2020 10-K 29 Mar 2022 2021 FY
Q3 2020 $81,000 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021 2021 Q3
Q2 2020 $80,000 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q2
Q1 2020 $37,000 +$29,000 +362% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1
Q1 2019 $8,000 +$2,000 +33% 01 Jan 2019 31 Mar 2019 10-Q 08 May 2020 2020 Q1
Q1 2018 $6,000 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019 2019 Q1

Tempest Therapeutics, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $389,000 +$8,000 +2.1% 01 Jan 2024 31 Dec 2024 10-K 27 Mar 2025 2024 FY
2023 $381,000 -$257,000 -40% 01 Jan 2023 31 Dec 2023 10-K 27 Mar 2025 2024 FY
2022 $638,000 +$264,000 +71% 01 Jan 2022 31 Dec 2022 10-K 19 Mar 2024 2023 FY
2021 $374,000 +$35,000 +10% 01 Jan 2021 31 Dec 2021 10-K 22 Mar 2023 2022 FY
2020 $339,000 +$242,000 +249% 01 Jan 2020 31 Dec 2020 10-K 29 Mar 2022 2021 FY
2019 $97,000 +$65,000 +203% 01 Jan 2019 31 Dec 2019 10-K 29 Mar 2021 2020 FY
2018 $32,000 +$4,000 +14% 01 Jan 2018 31 Dec 2018 10-K 11 Mar 2020 2019 FY
2017 $28,000 01 Jan 2017 31 Dec 2017 10-K 01 Apr 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.